Interleukin-2 gene therapy potentiates tha antitumor effect of cytostatic agent in mice with advanced transplantable tumors
Languages of publication
The combination of one dose of the cytostatic agent (bromoanalog of ifosfamide) administration with subsequent peritumoral injections of the cytokine-producing cells was observed to be more efficient in the tumor growth inhibition as compared with the cytostatic alone.
Publication order reference
H.Glazman-Kusnierczyk, Dept. of Tumor Immunology, L.Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Czerska St. 12, 53-114 Wroclaw, Poland